Retinoids, 585-nm laser, and carbon dioxide laser: a numeric comparison of neocollagen formation in photoaged hairless mouse skin. [2008.11]
Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication. [2008.09.22]
Combined retinol-lactose-glycolic acid effects on photoaged skin: a double-blind placebo-controlled study. [2008.06]
Use of oral isotretinoin in photoaging therapy. [2008.01]
Influence of retinoids on skin fibroblasts metabolism in vitro. [2008.01]
Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin. [2007.06]
The use of retinoids in the treatment of photoaging. [2006.09]
A newly synthesized photostable retinol derivative (retinyl N-formyl aspartamate) for photodamaged skin: profilometric evaluation of 24-week study. [2006.08]
Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens. [2005.04]
The mechanism of action of topical retinoids. [2005.02]
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. [2005.02]
Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin. [2004.12]
Facial tolerability of topical retinoid therapy. [2004.11]
Topical beta-carotene is converted to retinyl esters in human skin ex vivo and mouse skin in vivo [In Process Citation] [2004.09]
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. [2004.06]
Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging. [2004.05]
Penetration and metabolism of topical retinoids in ex vivo organ-cultured full-thickness human skin explants. [2004.05]
Tazarotene 0.1% cream for the treatment of photodamage. [2004.04]
Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations. [2003.12]
Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. [2003.07]
Retinoids: fascinating up-and-coming scenario. [2003.05]
Optimizing treatment with topical tazarotene. [2003.01]
Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin. [2003]
Optimizing treatment with topical tazarotene. [2003]
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. [2002.11]
Instrumental evaluation of retinoid-induced skin irritation. [2002.05]
Treatment of acne by isotretinoin (general course) [2002.04.15]
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy. [2002.02]
The antibacterial activity of topical retinoids: the case of retinaldehyde. [2002]
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. [2001.12]
Isotretinoin effects on bone. [2001.11]
Retinoids--which dermatological indications will benefit in the near future? [2001.09]
Developments in topical retinoid therapy for acne. [2001.09]
Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies. [2001.08]
Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris. [2001.06]
Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. [2001.06]
Tretinoin peeling. [2001.01]
Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris. [2001.01]
Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. [2001.01]
A double-blind investigation of the potential systemic absorption of isotretinoin, when combined with chemical sunscreens, following topical application to patients with widespread acne of the face and trunk. [2001.01]
Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel. [2000.10]
Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. [2000.08]
Pharmacokinetics and safety of tazarotene. [2000.08]
A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0.025%, in reducing facial shine. [2000.08]
Recent developments in receptor-selective retinoids. [2000.06]
Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. [2000.01]
Interactions between tazarotene and ultraviolet light. [1999.12]
Comparative irritancy study among retinoid creams and gels. [1999.10]
Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis. [1999.10]
1 2 Next >>
